4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000133
EVP, Chief Business Officer sold 6,659 shares at an average $79.74 ($530,987)
- EVP, Chief Business Officer acquired 2,138 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Baroldi Joseph EVP, Chief Business Officer | 2026-03-03 | Sale 10b5-1 | −4,096 | $79.36 | $325,059 | 41,317 | D: show line 1 in the form |
| Baroldi Joseph EVP, Chief Business Officer | 2026-03-03 | Option exercise 10b5-1 | +820 | $56.78 | $46,560 | 5,592 | I: show line 2 in the form |
| Baroldi Joseph EVP, Chief Business Officer | 2026-03-03 | Option exercise 10b5-1 | +879 | $32.60 | $28,655 | 6,471 | I: show line 3 in the form |
| Baroldi Joseph EVP, Chief Business Officer | 2026-03-03 | Sale 10b5-1 | −2,088 | $80.41 | $167,892 | 4,383 | I: show line 4 in the form |
| Baroldi Joseph EVP, Chief Business Officer | 2026-03-03 | Sale 10b5-1 | −36 | $81.01 | $2,916 | 4,347 | I: show line 5 in the form |
| Baroldi Joseph EVP, Chief Business Officer | 2026-03-04 | Option exercise 10b5-1 | +238 | $56.78 | $13,514 | 4,585 | I: show line 6 in the form |
| Baroldi Joseph EVP, Chief Business Officer | 2026-03-04 | Sale 10b5-1 | −238 | $80.00 | $19,040 | 4,347 | I: show line 7 in the form |
| Baroldi Joseph EVP, Chief Business Officer | 2026-03-04 | Option exercise 10b5-1 | +201 | $32.60 | $6,553 | 4,548 | I: show line 8 in the form |
| Baroldi Joseph EVP, Chief Business Officer | 2026-03-04 | Sale 10b5-1 | −201 | $80.00 | $16,080 | 4,347 | I: show line 9 in the form |
| Open-market sales · 6,659 sh · avg $79.74 · $530,987 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Baroldi Joseph EVP, Chief Business Officer | 2026-03-03 | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −879 | 1,970 | I: show line 10 in the form | ||
| Baroldi Joseph EVP, Chief Business Officer | 2026-03-04 | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −201 | 1,769 | I: show line 11 in the form | ||
| Baroldi Joseph EVP, Chief Business Officer | 2026-03-03 | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −820 | 4,104 | I: show line 12 in the form | ||
| Baroldi Joseph EVP, Chief Business Officer | 2026-03-04 | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −238 | 3,866 | I: show line 13 in the form |
Loading xslF345X05/edgardoc.xml…